Steven Cohen's PCVX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 161,614 shares of Vaxcyte, Inc. (PCVX) worth $7.46 M, representing 0.01% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in PCVX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 696,843 shares. Largest reduction occurred in Q4 2023, reducing 621,030 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Vaxcyte (PCVX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vaxcyte (PCVX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -535,229 | Reduce 76.81% | 161,614 | $46.14 |
| Q3 2025 | +696,843 | New Buy | 696,843 | $36.02 |
| Q2 2025 | -245,317 | Sold Out | 0 | $0.00 |
| Q1 2025 | -5,738 | Reduce 2.29% | 245,317 | $37.76 |
| Q4 2024 | -108,741 | Reduce 30.22% | 251,055 | $81.86 |
| Q3 2024 | +359,796 | New Buy | 359,796 | $114.27 |
| Q1 2024 | -30,155 | Sold Out | 0 | $0.00 |
| Q4 2023 | -621,030 | Reduce 95.37% | 30,155 | $62.80 |
| Q3 2023 | +452,789 | Add 228.22% | 651,185 | $50.98 |
| Q2 2023 | -302,704 | Reduce 60.41% | 198,396 | $49.94 |
| Q1 2023 | +198,500 | Add 65.60% | 501,100 | $37.48 |
| Q4 2022 | -120,200 | Reduce 28.43% | 302,600 | $47.95 |
| Q3 2022 | +422,800 | New Buy | 422,800 | $24.00 |
Steven Cohen's Vaxcyte Investment FAQs
Steven Cohen first purchased Vaxcyte, Inc. (PCVX) in Q3 2022, acquiring 422,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Vaxcyte, Inc. (PCVX) for 13 quarters since Q3 2022.
Steven Cohen's largest addition to Vaxcyte, Inc. (PCVX) was in Q3 2025, adding 696,843 shares worth $25.1 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 161,614 shares of Vaxcyte, Inc. (PCVX), valued at approximately $7.46 M.
As of the Q4 2025 filing, Vaxcyte, Inc. (PCVX) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Vaxcyte, Inc. (PCVX) was 696,843 shares, as reported at the end of Q3 2025.